Askiel Bruno

Askiel Bruno is a Professor at Augusta University's Medical College of Georgia, Department of Neurology, holding the Amy G. Warren and Lamar Warren Distinguished Chair in Diabetes and Obesity in Radiology. Appointed Distinguished Professor by MCG in 2023, he also serves as Vice Chair for Clinical Research in the Neurology Department since 2023.

His educational background includes:

• Undergraduate and Master's degrees in Biochemistry from UCLA
• MD from New York University School of Medicine (1982)
• Neurology residency at West Los Angeles VA Hospital/UCLA
• Stroke Fellowship at the University of Iowa

Dr. Bruno specializes in stroke and cerebrovascular diseases, with research focusing on hypertension adherence in stroke prevention, hyperglycemia management in acute stroke, and white matter disease pathogenesis. His work addresses critical gaps in understanding racial disparities within the U.S. stroke belt and develops clinical protocols for optimizing functional outcomes through risk factor control and collateral circulation assessment. His methodology integrates clinical epidemiology with neuroimaging to advance personalized stroke care.

Analysis of his 2022-2023 publications reveals consistent emphasis on translational stroke research, particularly examining how vascular risk factors modulate stroke outcomes. Key trends include leveraging real-world data from the stroke belt, investigating white matter changes as biomarkers, and conducting subgroup analyses of clinical trials to identify patient-specific treatment responses. His work bridges basic science (white matter pathogenesis) with immediate clinical applications (hyperglycemia protocols).

His scientific recognition includes:

• Distinguished Professor, Medical College of Georgia (2023)
• Amy G. Warren and Lamar Warren Distinguished Chair in Diabetes and Obesity in Radiology (2015)

As Vice Chair for Clinical Research and long-standing committee member (Neurology Education Committee since 2010, Pharmacy & Therapeutics since 2012), Dr. Bruno drives research infrastructure development and clinical trial implementation. His leadership in the Albert Research Institute workshops demonstrates commitment to advancing white matter disease research through collaborative frameworks.

His active directorship roles (MCG Director since 2024, Neurology Committee since 2018) indicate ongoing institutional leadership in shaping clinical research strategy and neurology education.